Icahn School of Medicine at Mount Sinai and Rensselaer Polytechnic Institute Announce Academic Collaboration
May 22, 2013
Partnership will accelerate the pace of discovery and innovation in Biomedical Sciences.
Ketamine Shows Significant Benefit in People with Treatment-Resistant Depression
May 20, 2013
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic.
Degenerative Changes Identified in Spinal Discs and Reversed With Drug Cocktail In Diabetic Mice
May 17, 2013
The study, led by James C. Iatridis, PhD, was published in the journal PLOS ONE on May 17.
Icahn School of Medicine at Mount Sinai and Bene Pharmachem Gmbh To Collaborate On Clinical Studies For Mucopolysaccharidoses
May 15, 2013
The company, based in Germany, is the sole producer of pharmaceutical pentosan polysulfate.
Mount Sinai Researchers Identify Gene Mutations in Congenital Heart Disease
May 12, 2013
Using high-throughput sequencing, an international research team including Mount Sinai discovers causes of severe congenital heart disease
Mount Sinai Honors Innovators in Scientific Research and Health Care Philanthropy at 2013 Commencement
May 10, 2013
Nobel Prize-winner Daniel Kahneman, PhD, delivers keynote address and receives honorary degree
National Institute of Neurological Disorders and Stroke (NINDS) Stops Enrolling Patients in ARUBA Study Earlier than Planned
May 10, 2013
Mount Sinai’s International Center for Health Outcomes and Innovation Research (InCHOIR) is the data-coordinating center for the trial
Children Living Near Toxic Waste Sites in Developing Countries May Experience Higher Blood Lead Levels Resulting in Lower IQ
May 6, 2013
Mount Sinai researcher estimates that lead exposure could cause mental retardation in 6 in 1,000 children living near the sites.
Toxic Waste Sites Cause 'Healthy Years of Life Lost' for People Living in India, Philippines and Indonesia
May 4, 2013
Mount Sinai researcher presents novel findings in environmental health at the Pediatric Academic Societies.
American Association of Clinical Endocrinologists (AACE) Announces New President: Mount Sinai's Jeffrey Mechanick, MD
May 4, 2013
Mount Sinai researcher, Derek LeRoith, MD, receives distinction in Clinical Endocrinology Award at AACE’s Annual Scientific Sessions.
Sarcoma Foundation of America Honors Robert G. Maki, MD, PhD, with the Nobility in Science Award
April 29, 2013
Dr. Maki was recognized for his committment to finding a cure for sarcoma, a cancer of the connective tissue including bone, cartilage, muscle, and fat.
Inhibiting Enzymes in the Cell May Lead to Development and Proliferation of Cancer Cells
April 25, 2013
Blocking certain enzymes in the cell may prevent cancer cell division and growth, according to new findings from researchers at Mount Sinai
Scientists at Mount Sinai Discover a Key Mechanism for the Most Common Form of Alzheimer's Disease
April 25, 2013
Research identifies potential therapeutic targets for Late Onset Alzheimer's Disease (LOAD) by revealing a network of genes involved in the inflammatory response.
Cancer-Incidence Rates Higher Than Expected Among World Trade Center Rescue and Recovery Workers
April 23, 2013
Comprehensive study by Mount Sinai’s WTC Health Program published in Environmental Health Perspectives.
Kenneth Davis, MD, President and CEO of The Mount Sinai Medical Center, Spoke on the Future of Medicine at the Aspen Ideas Festival Preview in New York City
April 19, 2013
Mount Sinai will be the first medical center sponsor of the Aspen Ideas Festival.
Mount Sinai Launches Phase III Clinical Trial of Novel, Personalized Vaccine for Newly-Diagnosed Kidney Cancer
April 17, 2013
Study will examine potential of investigational immunotherapy AGS-003 to improve survival when combined with standard kidney cancer treatment.